Where the blockbuster weight loss drug market stands today — and what’s coming next
Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.
Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals
Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...
Obesity Drugs May Drop to as Little as $149 a Month
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
U.S. News & World Report
Novo, Lilly's Shares Drop as Trump Vows Weight-Loss Drug Price Cuts
COPENHAGEN (Reuters) -Shares of weight-loss drug makers Novo Nordisk and Eli Lilly fell on Friday after U.S. President Donald Trump said that the price of Novo's popular Ozempic treatment would be ...
Hosted on MSN
Novo Nordisk (NVO) and Eli Lilly (LLY): Weight-Loss Drug Stocks Dip on Trump’s New Price Promise
Novo Nordisk (NVO) and Eli Lilly & Co. (LLY) shares are trending lower in pre-market trading after President Donald Trump said the price of Ozempic, Novo’s top-selling weight-loss and diabetes drug, ...
Benzinga.com
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs'
Shares of Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are moving lower in Thursday’s after-hours session after President Donald Trump indicated that weight-loss drugs are going to come ...
Yahoo
Lilly's weight-loss pill shows better blood sugar control in late-stage trials
FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly's experimental ...
Yahoo
Eli Lilly allows Cipla to sell weight loss drug under new brand in India
FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo FILE PHOTO: The Eli Lilly logo is shown on one ...
Morningstar
Eli Lilly's Weight-Loss Drug Meets Primary Endpoint in Diabetes Trials
Eli Lilly said its investigational oral GLP-1 weight-loss drug, orforglipron, met its primary endpoints in two recent phase 3 trials. The medicine company said Wednesday the drug met the primary and ...
Seeking Alpha
Eli Lilly oral weight loss drug succeeds in late-stage trials for diabetes
Eli Lilly (NYSE:LLY) announced on Wednesday that its oral weight loss candidate, orforglipron, reached the main goals in two Phase 3 trials for patients with type 2 diabetes, indicating its potential ...
Seeking Alpha
Eli Lilly gives Cipla license to sell weight-loss drug Tirzepatide in India
Eli Lilly (NYSE:LLY) has partnered with India's Cipla to market its weight-loss medication Tirzepatide under a new brand in the country. According to the agreement announced by the companies, Lilly ...